文献速递神经康复骨科与运动康复

约束诱导运动疗法对多发性硬化白质完整性的II期随机对照试验:第二部分

Phase II Randomized Controlled Trial of Constraint-Induced Movement Therapy in Multiple Sclerosis. Part 2: Effect on White Matter Integrity.
PubMed 文献 · Neurorehabil Neural Repair · 2018-01-01

结果发现CIMT组运动活动日志改善显著优于CAM组(P<.001),且CIMT后多个白质区域完整性指标出现改善(FA、AD、MD、RD的P<.05)。初步提示CIMT可能逆转MS导致的白质完整性损害。

要点

  • CIMT组MAL改善显著优于CAM组(P<.001),组内效应量3.7(d'=0.57)。
  • CIMT后对侧胼胝体FA、同侧枕上回AD、同侧颞上回FA、对侧皮质脊髓束MD和RD均改善(P<.05)。
  • 初步提示CIMT可能逆转MS所致白质完整性损害。

核心结论

  • CIMT在偏瘫型MS患者中产生非常大的真实世界肢体使用改善,并诱导白质改变。
  • 初步提示MS导致的白质完整性不良改变可能被CIMT逆转。

研究设计与样本

  • 采用基于纤维束的空间统计(TBSS)评估结构白质改变,指标包括FA、MD、AD、RD。

主要发现

  • CIMT与CAM组治疗前残疾程度或获益预期无差异。
  • CIMT组MAL改善优于CAM组(P<.001),CIMT组内效应量3.7(d'=0.57),CAM仅0.7。
  • CIMT后白质完整性改善见于对侧胼胝体(FA,P<.05)、同侧枕上回(AD,P<.05)、同侧颞上回(FA,P<.05)、对侧皮质脊髓束(MD和RD,P<.05)。

关键数值与推荐

  • CIMT组MAL改善的组内效应量为3.7(d'=0.57),CAM组为0.7。
  • 白质完整性改善的显著性阈值均为P<.05。

临床怎么用

  • 对慢性偏瘫型MS患者,CIMT可改善真实世界肢体使用并可能诱导白质完整性改变。
  • 临床可考虑将CIMT作为MS偏瘫患者的一种康复干预选择。

局限性

  • 白质完整性改善为初步发现,需进一步研究确认。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Constraint-induced movement therapy (CIMT) is a method of physical rehabilitation that has demonstrated clinical efficacy in patients with chronic stroke, cerebral palsy, and multiple sclerosis (MS). OBJECTIVE: This pilot randomized controlled trial tested whether CIMT can also induce increases in white matter integrity in patients with MS. METHODS: Twenty adults with chronic hemiparetic MS were randomized to receive either CIMT or complementary and alternative medicine (CAM) treatment (reported in the first article of this pair). Structural white matter change was assessed by tract-based spatial statistics (TBSS); measures included fractional anisotropy (FA), mean diffusivity (MD), axial diffusivity (AD), and radial diffusivity (RD). RESULTS: CIMT and CAM groups did not differ in pretreatment disability or expectancy to benefit. As noted in the companion paper, the motor activity log (MAL) improved more after CIMT than CAM ( P < .001); the within-group effect size for CIMT was 3.7 (large d' = 0.57), while for CAM it was just 0.7. Improvements in white matter integrity followed CIMT and were observed in the contralateral corpus callosum (FA, P < .05), ipsilateral superior occipital gyrus (AD, P < .05), ipsilateral superior temporal gyrus (FA, P < .05), and contralateral corticospinal tract (MD and RD, P < .05). CONCLUSION: CIMT produced a very large improvement in real-world limb use and induced white matter changes in patients with hemiparetic MS when compared with CAM. The findings suggest in preliminary fashion that the adverse changes in white matter integrity induced by MS might be reversed by CIMT. CLINICAL TRIAL REGISTRATION NUMBER: ClinicalTrials.gov (NCT01081275).

来源:Neurorehabil Neural Repair,查看原文。版权归原作者所有。

引用

  1. Barghi A, Allendorfer JB, Taub E, et al. Phase II Randomized Controlled Trial of Constraint-Induced Movement Therapy in Multiple Sclerosis. Part 2: Effect on White Matter Integrity. Neurorehabil Neural Repair. 2018. PMID: 29668401. doi:10.1177/1545968317753073

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。